Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/16160172

Download in:

View as

General Info

PMID
16160172